Last reviewed · How we verify
NCT03573661: BCL
A Pilot Multi-Institutional Study to Evaluate the Accuracy of a Breast Cancer Locator in Patients With Palpable Cancers
NA trial testing Breast Cancer Locator (BCL) in Palpable Breast Cancer in 18 participants. Completed in 5 April 2021.
24 March 2021
Quick facts
| Lead sponsor | Dartmouth-Hitchcock Medical Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | device feasibility |
| Enrollment | 18 |
| Start date | 24 May 2018 |
| Primary completion | 24 March 2021 |
| Estimated completion | 5 April 2021 |
| Sites | 4 locations across United States |
Drugs / interventions tested
- Breast Cancer Locator (BCL)
Conditions studied
- Palpable Breast Cancer — all drugs for Palpable Breast Cancer →
Sponsor
Dartmouth-Hitchcock Medical Center
Who can join
18 and older, female only, with Palpable Breast Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The project objective is to determine whether the Breast Cancer Locator (BCL) can safely and effectively localize breast cancers in patients treated at locations distant from the site of BCL manufacture. This information will be transmitted to CairnSurgical, Inc. where the BCL will be fabricated, tested for quality assurance, sterilized and shipped to the patient's surgeon. The surgeon will then utilize the BCL at the time of resection of the palpable breast cancer.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
A quantitative method to compare regional tumor contrast between prone and supine breast MRI.
Byrd BK, Krishnaswamy V, Fox MJ, Gui J, et al · · 2026 · PMID 42125694 · DOI 10.3389/fonc.2026.1479189 -
A quantitative method to compare regional tumor contrast between prone and supine breast MRI
Byrd BK, Krishnaswamy V, Fox MJ, Gui J, et al · · 2024 · DOI 10.21203/rs.3.rs-3919303/v1
Verify or expand the search:
- PubMed search for NCT03573661
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Dartmouth-Hitchcock Medical Center trials
Trials by the same sponsor.
- NCT07325474 — Plan and Protect: Safety Planning for Teens in Rural Emergency Departments · NA · not yet recruiting
- NCT07428629 — Piloting an Insomnia Treatment in Patients With Ulcerative Colitis · NA · not yet recruiting
- NCT06777511 — Advancing Antimicrobial Photodynamic Therapy to Prevent Infection in Osseointegrated Prosthesis Patients · not yet recruiting
- NCT07279116 — ABY-029 Head & Neck Trial · Phase 1 · not yet recruiting
- NCT07063693 — ABY-029 Glioma Trial · Phase 1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03573661 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dartmouth-Hitchcock Medical Center
- Last refreshed: 25 May 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03573661.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing